StockNews.com started coverage on shares of Oxbridge Re (NASDAQ:OXBR – Free Report) in a research note released on Tuesday morning. The brokerage issued a hold rating on the insurance provider’s stock.
Oxbridge Re Price Performance
Shares of OXBR stock opened at $4.13 on Tuesday. The firm’s 50-day moving average is $3.35 and its two-hundred day moving average is $2.81. Oxbridge Re has a 12 month low of $0.87 and a 12 month high of $4.96. The company has a market capitalization of $24.93 million, a PE ratio of -4.92 and a beta of 0.98.
Hedge Funds Weigh In On Oxbridge Re
A hedge fund recently raised its stake in Oxbridge Re stock. Geode Capital Management LLC boosted its position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 3.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 129,294 shares of the insurance provider’s stock after purchasing an additional 4,141 shares during the period. Geode Capital Management LLC owned approximately 2.14% of Oxbridge Re worth $359,000 at the end of the most recent quarter. 5.64% of the stock is owned by institutional investors.
About Oxbridge Re
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
Featured Stories
- Five stocks we like better than Oxbridge Re
- Manufacturing Stocks Investing
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Options Trading – Understanding Strike Price
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.